Biology Reference
In-Depth Information
Nimer LR, Needleman DH, Hamilton SL, Krall J, Movsesian MA (1995) Effect of ryanodine on
sarcoplasmic reticulum Ca2+ accumulation in nonfailing and failing human myocardium.
Circulation 92:2504-2510
Ockaili R, Salloum F, Hawkins J, Kukreja RC (2002) Sildenafil (Viagra) induces powerful
cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol
Heart Circ Physiol 283:H1263-H1269
Pokreisz P, Vandenwijngaert S, Bito V et al (2009) Ventricular phosphodiesterase-5 expression is
increased in patients with advanced heart failure and contributes to adverse ventricular
remodeling after myocardial infarction in mice. Circulation 119:408-416
Reiken S, Gaburjakova M, Guatimosim S et al (2003) Protein kinase A phosphorylation of the
cardiac calcium release channel (ryanodine receptor) in normal and failing heartsRole of
phosphatases and response to isoproterenol. J Biol Chem 278:444-453
Salloum F, Yin C, Xi L, Kukreja RC (2003) Sildenafil induces delayed preconditioning through
inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 92:595-597
Salloum FN, Abbate A, Das A et al (2008) Sildenafil (Viagra) attenuates ischemic cardiomyopathy
and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol 294:
H1398-H1406
Salloum FN, Chau VQ, Hoke NN et al (2009) Phosphodiesterase-5 inhibitor, tadalafil, protects
against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of
hydrogen sulfide. Circulation 120:S31-S36
Sculptoreanu A, Rotman E, Takahashi M, Scheuer T, Catterall WA (1993) Voltage-dependent
potentiation of the activity of cardiac L-type calcium channel alpha 1 subunits due to phos-
phorylation by cAMP-dependent protein kinase. Proc Natl Acad Sci USA 90:10135-10139
Shakur Y, Takeda K, Kenan Y et al (2000) Membrane localization of cyclic nucleotide phospho-
diesterase 3 (PDE3). Two N-terminal domains are required for the efficient targeting to, and
association of, PDE3 with endoplasmic reticulum. J Biol Chem 275:38749-38761
Shimizu K, Shintani Y, Ding WG, Matsuura H, Bamba T (2002) Potentiation of slow component
of delayed rectifier K(+) current by cGMP via two distinct mechanisms: inhibition of phos-
phodiesterase 3 and activation of protein kinase G. Br J Pharmacol 137:127-137
Simmerman HK, Jones LR (1998) Phospholamban: protein structure, mechanism of action, and
role in cardiac function. Physiol Rev 78:921-947
Sinoway LS, Maskin CS, Chadwick B, Forman R, Sonnenblick EH, Le Jemtel TH (1983) Long-
term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in
cardiac performance and progression of the underlying disease. J Am Coll Cardiol 2:327-331
Suckau L, Fechner H, Chemaly E et al (2009) Long-term cardiac-targeted RNA interference for
the treatment of heart failure restores cardiac function and reduces pathological hypertrophy.
Circulation 119:1241-1252
Takasago T, Imagawa T, Shigekawa M (1989) Phosphorylation of the cardiac ryanodine receptor
by cAMP-dependent protein kinase. J Biochem (Tokyo) 106:872-877
Takimoto E, Champion HC, Li M et al (2005) Chronic inhibition of cyclic GMP phosphodiester-
ase 5A prevents and reverses cardiac hypertrophy. Nat Med 11:214-222
Takimoto E, Belardi D, Tocchetti CG et al (2007) Compartmentalization of cardiac beta-adrener-
gic inotropy modulation by phosphodiesterase type 5. Circulation 115:2159-2167
Uretsky BF, Generalovich T, Reddy PS, Spangenberg RB, Follansbee WP (1983) The acute
hemodynamic effects of a new agent, MDL 17, 043, in the treatment of congestive heart
failure. Circulation 67:823-828
Vandecasteele G, Verde I, Rucker-Martin C, Donzeau-Gouge P, Fischmeister R (2001) Cyclic
GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes. J Physiol
533:329-340
Vandeput F, Wolda SL, Krall J et al (2007) Cyclic nucleotide phosphodiesterase PDE1C1 in
human cardiac myocytes. J Biol Chem 282:32749-32757
Vandeput F, Krall J, Ockaili R et al (2009) cGMP-hydrolytic activity and its inhibition by sildenafil
in normal and failing human and mouse myocardium. J Pharmacol Exp Ther 330:884-891
Search WWH ::




Custom Search